SEC Form 4 · accession 0001127602-16-036864
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry J Merlo
Officer — President and CEO · Director
Period of report
Jan 11, 2016
Accepted (ET)
Jan 13, 2016 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 11, 2016 | M | 46,393 | $28.10 | A | 208,006 | D | |
| Common Stock | Jan 11, 2016 | S | 46,393 | $95.00 | D | 161,613 | D | |
| Common Stock | holding | — | — | — | 350,492 | I | By Trust As Beneficiary |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2 | $28.10 | Jan 11, 2016 | M | 46,393 | D | Apr 1, 2010 | Apr 1, 2016 | Common Stock | 46,393 | 46,393 | D |
Explanation of responses
- F1All sales were effected pursuant to a Rule 10b5-1 plan.
- F2Option became exercisable in three equal annual installments, commencing 4/1/2010.